Repros Therapeutics Inc (NASDAQ:RPRX)

8.43
Delayed Data
As of Apr 24
 -0.06 / -0.71%
Today’s Change
5.92
Today|||52-Week Range
22.55
-15.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-12.5M-18.2M-27.7M-32.5M
 
 
 
 
 
Depreciation115.0K145.0K257.0K43.0K
 
 
 
 
 
Total Other Cash Flow2.3M2.8M3.2M3.8M
 
 
 
 
 
Funds From Operations-10.1M-15.2M-24.3M-28.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-329.0K-1.7M142.0K626.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-9.8M-13.5M-24.4M-29.3M
 
 
 
 
 
 
InvestingCapital Expenditures-15.0K-30.0K-911.0K0.00
 
 
 
 
Net Cash Flow Investing-335.0K-608.0K-911.0K0.00
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale11.7M33.8M77.0M147.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing11.7M33.8M77.0M147.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash1.6M19.6M51.6M-29.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account